Volume 74, Issue 3 pp. 1384-1394
Original Article

State-Level HCC Incidence and Association With Obesity and Physical Activity in the United States

Yi-Te Lee

Yi-Te Lee

California Nano Systems Institute, Crump Institute for Molecular Imaging, Department of Molecular and Medical Pharmacology, University of California, Los Angeles, Los Angeles, CA

Search for more papers by this author
Jasmine J. Wang

Jasmine J. Wang

California Nano Systems Institute, Crump Institute for Molecular Imaging, Department of Molecular and Medical Pharmacology, University of California, Los Angeles, Los Angeles, CA

Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA

Search for more papers by this author
Michael Luu

Michael Luu

Biostatistics and Bioinformatics Research Center, Cedars-Sinai Medical Center, Los Angeles, CA

Search for more papers by this author
Hsian-Rong Tseng

Hsian-Rong Tseng

California Nano Systems Institute, Crump Institute for Molecular Imaging, Department of Molecular and Medical Pharmacology, University of California, Los Angeles, Los Angeles, CA

Search for more papers by this author
Nicole E. Rich

Nicole E. Rich

Division of Digestive and Liver Diseases, UT Southwestern Medical Center, Dallas, TX

Search for more papers by this author
Shelly C. Lu

Shelly C. Lu

Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA

Karsh Division of Gastroenterology and Hepatology, Cedars-Sinai Medical Center, Los Angeles, CA

Search for more papers by this author
Nicholas N. Nissen

Nicholas N. Nissen

Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA

Comprehensive Transplant Center, Cedars-Sinai Medical Center, Los Angeles, CA

Search for more papers by this author
Mazen Noureddin

Mazen Noureddin

Karsh Division of Gastroenterology and Hepatology, Cedars-Sinai Medical Center, Los Angeles, CA

Comprehensive Transplant Center, Cedars-Sinai Medical Center, Los Angeles, CA

Search for more papers by this author
Amit G. Singal

Amit G. Singal

Division of Digestive and Liver Diseases, UT Southwestern Medical Center, Dallas, TX

Search for more papers by this author
Ju Dong Yang

Corresponding Author

Ju Dong Yang

Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA

Karsh Division of Gastroenterology and Hepatology, Cedars-Sinai Medical Center, Los Angeles, CA

Comprehensive Transplant Center, Cedars-Sinai Medical Center, Los Angeles, CA

ADDRESS CORRESPONDENCE AND REPRINT REQUESTS TO:

Ju Dong Yang, M.D., M.S.

Karsh Division of Gastroenterology and Hepatology, Samuel Oschin Comprehensive Cancer Institute, Comprehensive Transplant Center, Cedars-Sinai Medical Center

8900 Beverly Blvd.

Los Angeles, CA 90048

E-mail: [email protected]

Tel.: +1-310-423-1971

Search for more papers by this author
First published: 17 March 2021
Citations: 6
Supported by the American College of Gastroenterology Junior Faculty Development Award, Department of Defense Peer Reviewed Cancer Research Program Career Development Award, Cedars-Sinai Clinical Scholar Award, and the Huiying Foundation (to J.D.Y.) and the National Institutes of Health (R01 MD12565 to A.G.S.).
Potential conflict of interest: Dr. Tseng received grants from Sorrento. He owns stock in CytoLumina and Pulsar. Dr. Noureddin advises and received grants from Allergan, Gilead, and Novartis. He received grants and owns stock in Viking. He advises 89BIO, Intercept, Pfizer, Novo Nordisk, Blade, EchoSens, Fractyl, Terns, OWL, Siemens, Roche, and Abbott. He received grants from Bristol-Myers Squibb, Galmed, Galectin, Genfit, Conatus, Enanta, Madrigal, Shire, and Zydus. He owns stock in Anaetos. Dr. Singal has been on advisory boards and served as a consultant for Wako Diagnostics, Glycotest, Exact Sciences, Roche, GRAIL, Genentech, Bayer, Eisai, BMS, Exelixis, AstraZeneca, and TARGET RWE. Dr. Yang consults for Exact Sciences, Eisai and Gilead.

Abstract

Background and Aims

Hepatocellular carcinoma (HCC) remains a leading cause of cancer-related mortality, with a disproportionate impact on racial/ethnic minority groups. However, state-level variation in racial/ethnic disparities and temporal trends of HCC incidence remain unknown. Therefore, we aimed to characterize (1) state-level racial/ethnic disparity in HCC incidence, (2) state-level temporal changes in HCC incidence, and (3) the ecological correlation between HCC incidence and obesity/physical activity levels in the USA.

Approach and Results

Trends in HCC incidence between 2001 and 2017 were calculated using data from the Centers for Disease Control and Prevention’s National Program of Cancer Registries and the National Cancer Institute’s Surveillance, Epidemiology and End Results, and annual percent change in rates were calculated. State-level percent of obesity and level of physical activity were obtained from the Centers for Disease Control and Prevention, and the correlation among obesity, physical activity, and state-specific average annual percent change was tested by Pearson correlation coefficient. There were striking state-level racial/ethnic disparities in HCC incidence; incidence rate ratios ranged between 6.3 and 0.9 in Blacks, 6.1 and 1.7 in Asians/Pacific Islanders, 3.8 and 0.9 in Hispanics, and 6.0 and 0.9 in American Indians/Alaska Natives (compared with Whites as reference). Despite overall decreasing HCC incidence rates after 2015, HCC incidence continued increasing in 26 states over recent years. HCC incidence trends had a moderate correlation with state-level obesity (r = 0.45, P < 0.001) and a moderate inverse correlation with state-level physical activity (r = −0.40, P = 0.004).

Conclusions

There is wide state-level variation in racial/ethnic disparity of HCC incidence. There are also disparate incidence trends across states, with HCC incidence continuing to increase in over half of the states. Regional obesity and lack of physical activity have moderate correlations with HCC incidence trends, suggesting that interventions targeting these factors may help curb rising HCC incidence.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.